Follow The Filings

TRV Travelers

Financials, filed as TRAVELERS COMPANIES INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 2

  • 1 Owner
  • #291
  • Max 3.8%
  • Master 0.01%
  • $11M
  • 1 reduce

In 2026 Q3 Murphy Pohlad trimmed Travelers.

Who owns this now

Largest portfolio weights among holders, up to 3.8% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Reduce 3.8%

Who owns TRV

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 3.8% Reduce −4.8% 30,306 $11M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by TRV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TRV insider trades
  • None no insider bought on the open market
  • $171M sold by 14 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Andy F Bessette EVP and Chief Admin Officer
    Sale
    $1.2M 3,000 shares at $399.35 14% of stake
    Traded Oct 28 Filed Oct 29
    ↗
  2. Mojgan M Lefebvre EVP & Chief Tech & Ops Officer
    Sale
    $4.3M 11,000 shares at $393.84 100% of stake
    Traded Oct 27 Filed Oct 28
    ↗
  3. Alan D Schnitzer CEO
    Sale
    $35.3M 88,900 shares at $396.77 23% of stake
    Traded Oct 21 Filed Oct 23
    ↗
  4. Gregory C Toczydlowski EVP & President, Business Ins.
    Sale
    $14M 34,771 shares at $403.89 65% of stake
    Traded Oct 22 Filed Oct 23
    ↗
  5. David Donnay Rowland EVP & Co-Chief Invest. Officer
    Sale
    $2M 5,000 shares at $405.62 32% of stake
    Traded Oct 22 Filed Oct 23
    ↗
  6. Jeffrey P. Klenk EVP & Pres., Bond & Spec. Ins.
    Sale
    $3.7M 9,016 shares at $405.57 60% of stake
    Traded Oct 22 Filed Oct 23
    ↗
  7. Maria Olivo EVP, ERM & Chief Risk Officer
    Sale
    $6M 15,100 shares at $398.44 13% of stake
    Traded Oct 21 Filed Oct 22
    ↗
  8. Michael Frederick Klein EVP & President, Personal Ins.
    Sale
    $2.9M 7,500 shares at $392.79 14% of stake
    Traded Oct 20 Filed Oct 22
    ↗
  9. Maria Olivo EVP, ERM & Chief Risk Officer
    Sale
    $2.2M 6,000 shares at $369.86 4.8% of stake
    Traded Aug 28 Filed Aug 31
    ↗
  10. Daniel Tei-Hwa Yin EVP & Co-Chief Invest. Officer
    Sale
    $2.8M 7,153 shares at $387.00 9.4% of stake
    Traded Jul 24 Filed Jul 27
    ↗
  11. Diane Kurtzman EVP & Chief HR Officer
    Sale
    $1.6M 4,164 shares at $386.71 44% of stake
    Traded Jul 24 Filed Jul 27
    ↗
  12. David Donnay Rowland EVP & Co-Chief Invest. Officer
    Sale
    $1.9M 5,000 shares at $371.69 32% of stake
    Traded Jul 22 Filed Jul 24
    ↗
  13. Paul E. Munson SVP & Corp. Controller
    Sale
    $564K 1,525 shares at $369.91 68% of stake
    Traded Jul 22 Filed Jul 24
    ↗
  14. Andy F Bessette EVP and Chief Admin Officer
    Sale
    $1.1M 3,000 shares at $368.11 12% of stake
    Traded Jul 22 Filed Jul 24
    ↗
  15. Michael Frederick Klein EVP & President, Personal Ins.
    Sale
    $2.2M 6,000 shares at $366.09 12% of stake
    Traded Jul 21 Filed Jul 23
    ↗

Also filed in the last 12 months, not counted as buying or selling: 49 option exercises, 32 stock grants, 19 share withholdings for taxes, and 7 gifts.

Congress

4 members of Congress traded TRV in the last three years: 3 buys and 2 sales. 7 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Julia Letlow R-LA-5 Buy $1K–$15K Feb 20 filed Mar 12
  3. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025
  4. Val T. Hoyle D-OR-4Spouse Buy $1K–$15K Oct 29, 2024 filed Sep 12, 2025
  5. Tommy Tuberville R-ALJoint Sell $15K–$50K Oct 29, 2024 filed Nov 15, 2024

SEC filings

Recent issuer filings from EDGAR, 13 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 8.01,9.01 Filing Doc
424B3 Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated about 21 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $41.36B $46.42B $48.83B
Net income $2.99B $5B $6.29B
Net margin * 7.2% 10.8% 12.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $125.98B $133.19B $143.71B
Total equity $24.92B $27.86B $32.89B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $7.71B $9.07B $10.61B
Cash from investing -$6.82B -$7.26B -$7.65B
Cash from financing -$1.05B -$1.75B -$2.66B
Net change in cash -$149M $49M $314M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.